Allovir Historical Income Statement
| ALVR Stock | USD 0.54 0.01 1.89% |
Historical analysis of Allovir income statement accounts such as Interest Income of 5.5 M, Depreciation And Amortization of 591.1 K or Interest Expense of 3.6 M can show how well Allovir performed in making a profits. Evaluating Allovir income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Allovir's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Allovir latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Allovir is a good buy for the upcoming year.
Allovir |
About Allovir Income Statement Analysis
Allovir Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Allovir shareholders. The income statement also shows Allovir investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Allovir Income Statement Chart
Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Total Revenue
Total revenue comprises all receipts Allovir generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Allovir's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Allovir current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allovir. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Allovir Stock, please use our How to Invest in Allovir guide.At this time, Allovir's Net Interest Income is relatively stable compared to the past year. As of 11/28/2024, Interest Income is likely to grow to about 5.5 M, while Gross Profit is likely to drop (417.9 K).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 1.3M | 1.9M | 5.3M | 5.5M | Net Interest Income | 1.3M | 1.9M | 5.3M | 5.5M |
Allovir income statement Correlations
Click cells to compare fundamentals
Allovir Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Allovir income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | 2.1M | 1.3M | 1.3M | 1.9M | 5.3M | 5.5M | |
| Interest Income | 2.1M | 1.3M | 1.3M | 1.9M | 5.3M | 5.5M | |
| Depreciation And Amortization | 19K | 73K | 189K | 723K | 398K | 591.1K | |
| Selling General Administrative | 10.6M | 21.6M | 49.1M | 52.3M | 48.3M | 33.9M | |
| Gross Profit | 165K | (73K) | (1.1M) | (2.6M) | (398K) | (417.9K) | |
| Other Operating Expenses | 26.9M | 71.3M | 169.8M | 171.2M | 181.3M | 114.6M | |
| Operating Income | (26.7M) | (71.3M) | (169.8M) | (171.2M) | (181.3M) | (172.3M) | |
| Net Income From Continuing Ops | (23.8M) | (69.8M) | (172.0M) | (168.7M) | (168.9M) | (160.4M) | |
| Ebit | (26.7M) | (71.3M) | (169.8M) | (171.2M) | (190.5M) | (181.0M) | |
| Research Development | 16.2M | 49.7M | 120.7M | 118.9M | 133.1M | 80.7M | |
| Ebitda | (26.7M) | (71.2M) | (169.6M) | (170.5M) | (190.1M) | (180.6M) | |
| Total Operating Expenses | 26.9M | 71.3M | 169.8M | 171.2M | 180.9M | 114.6M | |
| Reconciled Depreciation | 19K | 73K | 189K | 723K | 343K | 247.0K | |
| Income Before Tax | (23.8M) | (69.8M) | (171.0M) | (169.0M) | (190.5M) | (181.0M) | |
| Total Other Income Expense Net | 2.9M | 1.5M | (1.1M) | 2.2M | (9.2M) | (8.8M) | |
| Net Income Applicable To Common Shares | (23.8M) | (69.8M) | (172.0M) | (168.7M) | (151.8M) | (144.2M) | |
| Net Income | (21.8M) | (68.4M) | (172.0M) | (168.7M) | (190.4M) | (180.9M) | |
| Income Tax Expense | (2.1M) | (1.4M) | 1.0M | (265K) | (126K) | (132.3K) |
Pair Trading with Allovir
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allovir position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will appreciate offsetting losses from the drop in the long position's value.Moving against Allovir Stock
| 0.47 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.43 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.42 | MNOV | MediciNova | PairCorr |
The ability to find closely correlated positions to Allovir could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allovir when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allovir - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allovir to buy it.
The correlation of Allovir is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allovir moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allovir moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allovir can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Allovir Stock Analysis
When running Allovir's price analysis, check to measure Allovir's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allovir is operating at the current time. Most of Allovir's value examination focuses on studying past and present price action to predict the probability of Allovir's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allovir's price. Additionally, you may evaluate how the addition of Allovir to your portfolios can decrease your overall portfolio volatility.